Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED) by Seini Moimoi | Jul 25, 2024 | Portfolio News
Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older by Seini Moimoi | Jul 25, 2024 | Portfolio News
Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function by Seini Moimoi | Jul 25, 2024 | Portfolio News
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round by Seini Moimoi | Jul 24, 2024 | Portfolio News
Ceribell Announces Publication of Study Demonstrating Significant Reduction in Length of ICU Stays and Better Patient Outcomes with Ceribell Point-of-Care EEG Compared to Conventional EEG by Seini Moimoi | Jul 22, 2024 | Portfolio News
